Advertisement
Canada markets open in 3 hours

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7265
    +0.0002 (+0.03%)
     

  • CRUDE OIL

    82.30
    -0.43 (-0.52%)
     

  • Bitcoin CAD

    89,332.63
    +4,433.78 (+5.22%)
     

  • CMC Crypto 200

    1,332.90
    +20.27 (+1.57%)
     

  • GOLD FUTURES

    2,397.00
    -1.00 (-0.04%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,433.00
    -114.25 (-0.65%)
     

  • VOLATILITY

    19.14
    +1.14 (+6.34%)
     

  • FTSE

    7,836.72
    -40.33 (-0.51%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6816
    -0.0005 (-0.07%)
     

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANAB, SERV and CONN

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / May 25, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

AnaptysBio, Inc. (ANAB)

Investors Affected : October 10, 2017 - November 7, 2019

A class action has commenced on behalf of certain shareholders in AnaptysBio, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) AnaptysBio failed to disseminate important data from the Company's Phase 2a trial in atopic dermatitis, including the timing and extent of patients' use of topical corticosteroids as a rescue therapy during the study and whether any of the patients that utilized rescue therapy were classified as responders at a given time;and (ii) the Company's statements omitted key information from the Company's Phase 2a trial in peanut allergy, including patients' average cumulative peanut dose tolerated at day 14 after the administration of etokimab or placebo as well as whether the Company's decision to exclude 20% of the patients enrolled in the study from the interim analysis due to their mild symptoms was retrospective; and (ii) as a result of the foregoing, Defendants' positive statements about the efficacy and prospects of AnaptysBio's lead drug asset in the treatment of atopic dermatitis and peanut allergy were materially false and/or misleading and/or lacked a reasonable basis.

ADVERTISEMENT

Shareholders may find more information at https://securitiesclasslaw.com/securities/anaptysbio-inc-loss-submission-form/?id=6860&from=1

Servicemaster Global Holdings, Inc. (SERV)

Investors Affected : February 26, 2019 - November 4, 2019

A class action has commenced on behalf of certain shareholders in Servicemaster Global Holdings, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) ServiceMaster had failed to properly inspect and treat for Formosan termite activity; (b) as a result thereof, the Company was and continued to experience a material adverse trend of costly litigation from injured customers which was not disclosed to investors; (c) in an unsuccessful attempt to mitigate this trend, Defendants had been taking remedial measures since at least 2018, including drastically raising prices for termite treatments in Mobile, Alabama to deter contract renewals; and (d) as a result of the foregoing, ServiceMaster's financial results were reasonably likely to be impacted, and would continue to impact the Company into 2020.

Shareholders may find more information at https://securitiesclasslaw.com/securities/servicemaster-global-holdings-inc-loss-submission-form/?id=6860&from=1

Conn's, Inc. (CONN)

Investors Affected : September 3, 2019 - December 9, 2019

A class action has commenced on behalf of certain shareholders in Conn's, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Conn's was experiencing an increase in first payment defaults and 60-plus day delinquencies; (2) as a result, Conn's was reasonably likely to record an increase to its provision for bad debts; (3) the Company made certain underwriting adjustments, including tightening its standards for new customers and online applicants; (4) as a result, the Company's same-store sales would be adversely impacted; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/conns-inc-loss-submission-form/?id=6860&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm



View source version on accesswire.com:
https://www.accesswire.com/591326/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-ANAB-SERV-and-CONN